Neurontin Articles
IVAX gets tentative OK for generic Neurontin
13 May 2002
UK pharma news in brief
22 April 2002
Pfizer contesting Neurontin lawsuit
25 March 2002
Euro epilepsy drug sales "to grow 17.2%/year"
19 February 2001
Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting
14 December 2000
US investigates W-L's Neurontin
6 April 2000
W-L's Neurontin efficacy vs amitriptyline?
16 September 1999
Warner-Lambert's Neurontin in social phobia
14 July 1999
Parke-Davis' Neurotin Potent In Neuropathic Pain
3 December 1998
Warner-Lambert's Profits Soar 37% In 1st Qtr
30 April 1998
W-L To Stay Independent As Product Line Improves
30 April 1998
W-L To Stay Independent As Product Line Improves
24 April 1998
Epilepsy Market Sees Strong Growth
29 July 1997
Declines In 1st Qtr At Warner-Lambert
5 May 1997
Strong Earnings Continue At Major US Drug Firms
10 February 1997
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Higher-Priced Drugs Set To Expand Epilepsy Market
12 February 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
US Drug Lag Does Not Exist, Claims FDA Study
15 January 1996
Parke-Davis' Neurontin in France...
16 October 1995
End Of Year Encouraging For US Companies
6 February 1995
WARNER-LAMBERT POSTS 1st QTR GROWTH
25 April 1994
CURRENCY AND CHARGES IMPACT 1993 US RESULTS
7 February 1994
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
THE DAWN OF A NEW ERA FOR EPILEPSY
27 September 1993
WARNER-LAMBERT CONSENT AGREEMENT
23 August 1993
DUPONT MERCK TO PROMOTE LAMICTAL
16 August 1993
COGNEX APPROVAL "IMMINENT"
19 July 1993
NEW HOPES FOR EPILEPSY TREATMENT
12 July 1993
PARKE-DAVIS' GABAPENTIN IN UK
31 May 1993
WELLCOME R&D PIPELINE: PART 2
17 May 1993
ALL HOPES ON COGNEX AT WARNER-LAMBERT
26 April 1993
NEUROPHARMACEUTICAL MARKET IN USA
19 April 1993
WARNER-LAMBERT A "SWEET SPOT IN A SOUR MARKET"
19 April 1993
JOUVEINAL PRODUCTS EFFECT ON W-L PIPELINE
8 February 1993
PROMISING RESULTS FOR DEZINAMIDE
21 December 1992
WARNER-LAMBERT'S VIEW TO THE FUTURE
27 April 1992
NEW DRUGS FOR EPILEPTICS
13 January 1992
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
